EARLY DIAGNOSIS, RISK STRATIFICATION, AND BIOMARKER-BASED ASSESSMENT OF CHRONIC KIDNEY DISEASE IN CHILDREN: AN INTEGRATED CLINICAL APPROACH

Abstract

Chronic kidney disease (CKD) in children represents a complex, multifactorial, and progressively evolving condition associated with significant long-term morbidity and risk of progression to end-stage renal disease. Early detection of chronic non-communicable diseases remains a global health priority, particularly in pediatric populations where clinical manifestations are often latent (World Health Organization [WHO], 2023). The asymptomatic nature of early-stage CKD necessitates the development and implementation of advanced diagnostic and preventive strategies based on evidence-based clinical frameworks.

This study aims to establish a comprehensive theoretical model for integrated diagnostic algorithms in pediatric practice, to evaluate etiological and pathophysiological risk factors associated with CKD progression, and to perform a comparative analysis of cystatin C and creatinine as biomarkers for early renal dysfunction. A systematic synthesis of international clinical guidelines and contemporary peer-reviewed literature was conducted, including recommendations from Kidney Disease: Improving Global Outcomes (KDIGO, 2024) and the National Institute for Health and Care Excellence (NICE, 2023).

The findings demonstrate that algorithm-based and risk-oriented diagnostic approaches significantly enhance early detection, improve risk stratification, and optimize clinical decision-making processes (Levey & Coresh, 2012). Major etiological determinants include congenital anomalies of the kidney and urinary tract, recurrent urinary tract infections, metabolic dysregulation, and hemodynamic alterations such as hypertension and diabetes mellitus (KDIGO, 2024).

Comparative analysis indicates that cystatin C exhibits superior sensitivity and specificity compared to serum creatinine, particularly in detecting early reductions in glomerular filtration rate (Inker et al., 2012; Shlipak et al., 2013). Unlike creatinine, cystatin C levels are minimally influenced by muscle mass, age, or nutritional status, thereby providing a more reliable assessment of renal function. Recent evidence suggests that combined biomarker models significantly improve the accuracy of estimated glomerular filtration rate (eGFR) and prognostic evaluation (Inker et al., 2012).

In conclusion, the integration of structured diagnostic algorithms with advanced biomarker assessment constitutes a highly effective strategy for early identification and management of CKD in children. The implementation of these approaches in pediatric clinical practice has the potential to significantly reduce disease progression, improve long-term outcomes, and enhance the overall quality of healthcare delivery..